[Anti-cytokine therapy for intractable hematologic diseases using monoclonal antibodies].
Norihiro
N
Nishimoto
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005871:Castleman Disease / Q000628:therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D015850:Interleukin-6 / Q000276:immunology* / Q000502:physiology*; D009101:Multiple Myeloma / Q000628:therapy*; D011788:Quality of Life; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors / Q000276:immunology / Q000502:physiology; D000093242:Interleukin-6 Inhibitors
D000911:Antibodies, Monoclonal; D015850:Interleukin-6; D019947:Receptors, Interleukin-6; D000093242:Interleukin-6 Inhibitors